Editorial: Drug repurposing for cancer treatment: current and future directions
Saved in:
Main Authors: | Marios Lampros, Nikolaos Vlachos, Georgios D. Lianos, Christina Bali, George A. Alexiou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1550672/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trifluridine-tipiracil in previously treated patients with oestrogen receptor-positive, HER2-negative metastatic breast cancer (BOOG 2019-01 TIBET trial): a single-arm, multicentre, phase 2 trialResearch in context
by: Niels A.D. Guchelaar, et al.
Published: (2025-02-01) -
Safety assessment of preventive pressurized intraperitoneal aerosol chemotherapy in combined treatment of gastric cancer: preliminary results
by: N. Ya. Muratova, et al.
Published: (2024-03-01) -
Efficacy of Lurasidone in First-Episode Psychosis: Patient Phenotypes, Dosage, and Recommendations from an Expert Panel
by: Miquel Bernardo, et al.
Published: (2025-01-01) -
Exploring the role of artificial intelligence in chemotherapy development, cancer diagnosis, and treatment: present achievements and future outlook
by: Bassam Abdul Rasool Hassan, et al.
Published: (2025-02-01) -
Impact of Bone-Modifying Agents on Post-Bone Metastasis Survival Across Cancer Types
by: Hironari Tamiya, et al.
Published: (2025-01-01)